BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17106152)

  • 21. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes.
    Mendes AI; Ferro A; Martins R; Picanço I; Gomes S; Cerqueira R; Correia M; Nunes AR; Esteves J; Fleming R; Faustino P
    Ann Hematol; 2009 Mar; 88(3):229-34. PubMed ID: 18762941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary hemochromatosis in north-eastern Romania.
    Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload.
    Porto G; Cardoso CS; Gordeuk V; Cruz E; Fraga J; Areias J; Oliveira JC; Bravo F; Gangaidzo IT; MacPhail AP; Gomo ZA; Moyo VM; Melo G; Silva C; Justiça B; de Sousa M
    Eur J Haematol; 2001 Aug; 67(2):110-8. PubMed ID: 11722599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
    Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
    Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary hemochromatosis].
    Niederau C
    Med Klin (Munich); 2009 Dec; 104(12):931-46. PubMed ID: 20039160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
    J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R.
    Lee PL; Barton JC
    Acta Haematol; 2006; 115(1-2):102-5. PubMed ID: 16424658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemochromatosis: genetics and pathophysiology.
    Beutler E
    Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients.
    Politou M; Kalotychou V; Pissia M; Rombos Y; Sakellaropoulos N; Papanikolaou G
    Haematologica; 2004 Apr; 89(4):490-2. PubMed ID: 15075083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC; Lee PL; West C; Bottomley SS
    Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.